Sun Pharma’s arm recalls 9,840 bottles of Morphine Sulfate extended-release tablets in US

17 Mar 2025 Evaluate

Sun Pharmaceutical Industries’ subsidiary -- Sun Pharmaceutical Industries Inc. is recalling 9,840 bottles of Morphine Sulfate extended-release tablets in the US market for ‘Failed Dissolution Specifications’. The company initiated the Class II nationwide (US) recall on February 6, 2025.

As per the USFDA, a Class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.


Sun Pharma Inds. Share Price

1717.00 -2.75 (-0.16%)
01-Jan-2026 13:19 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.00
Dr. Reddys Lab 1251.00
Cipla 1501.55
Zydus Lifesciences 912.50
Lupin 2101.95
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×